4
S02 - DR ANMOL_S ULTRASOUND CLINIC C-308, 3RD FLR, NIRWANA COUNTRY, SOUTH CITY GURGAON Name A/c Status Lab No. Ref By : Gender: Age: Report Status Reported Received Collected P 19/4/2014 4:55:01PM : : : : : : : Final 35 Years 19/4/2014 12:11:00PM 19/4/2014 12:22:25PM 107521815 Female SELF Ms. SUGANTHI Test Name Results Units Ref. Range ALBUMIN, SERUM (BCG) 4.45 g/dL 3.50 - 5.20 UREA, SERUM (Urease UV) 22.00 mg/dL 17.00 - 43.00 CREATININE, SERUM (Compensated Jaffe's reaction, IDMS traceable) 0.72 mg/dL 0.51 - 0.95 AST (SGOT), SERUM (IFCC) 15.00 U/L <35.00 ALT (SGPT), SERUM (IFCC) <10.00 U/L <35.00 BLOOD GROUP, ABO & RH TYPING @ (Erythrocyte Magnetized Technology) ABO Group B Rh Factor Positive Note: 1. Both forward and reverse grouping performed 2. Test conducted on EDTA whole blood PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 4) . Page 1 of 4

Su Gant Hi Reports

Embed Size (px)

DESCRIPTION

su

Citation preview

  • S02 - DR ANMOL_S

    ULTRASOUND CLINIC

    C-308, 3RD FLR, NIRWANA

    COUNTRY, SOUTH CITY

    GURGAON

    Name

    A/c Status

    Lab No.

    Ref By :

    Gender:Age:

    Report Status

    Reported

    Received

    Collected

    P

    19/4/2014 4:55:01PM

    :

    :

    :

    :

    :

    :

    : Final

    35 Years

    19/4/2014 12:11:00PM

    19/4/2014 12:22:25PM107521815 Female

    SELF

    Ms. SUGANTHI

    Test Name Results Units Ref. Range

    ALBUMIN, SERUM

    (BCG)

    4.45 g/dL 3.50 - 5.20

    UREA, SERUM

    (Urease UV)

    22.00 mg/dL 17.00 - 43.00

    CREATININE, SERUM

    (Compensated Jaffe's reaction, IDMS traceable)

    0.72 mg/dL 0.51 - 0.95

    AST (SGOT), SERUM

    (IFCC)

    15.00 U/L

  • S02 - DR ANMOL_S

    ULTRASOUND CLINIC

    C-308, 3RD FLR, NIRWANA

    COUNTRY, SOUTH CITY

    GURGAON

    Name

    A/c Status

    Lab No.

    Ref By :

    Gender:Age:

    Report Status

    Reported

    Received

    Collected

    P

    19/4/2014 4:55:05PM

    :

    :

    :

    :

    :

    :

    : Final

    35 Years

    19/4/2014 12:11:00PM

    19/4/2014 12:22:25PM107521815 Female

    SELF

    Ms. SUGANTHI

    Test Name Results Units Ref. Range

    HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD

    (HPLC)

    5.30 %

    Interpretation ------------------------------------------------------------------------------- | As per American Diabetes Association (ADA) ||-------------------------------------------------------------------------------| | Reference Group | HbA1c in % ||-------------------------------|-----------------------------------------------| | Non diabetic adults >=18 years| 4.0 - 6.0 | |-------------------------------|-----------------------------------------------| | At risk | >=6.0 to 6.5 ||-------------------------------|-----------------------------------------------|| Therapeutic goals for glycemic| Adults || control | . Goal of therapy: < 7.0 || | . Action suggested: > 8.0 || | Pediatric patients || | . Toddlers & Preschoolers: > 7.5 to < 8.5 || | . 6 - 12 years : < 8.0 || | . 13 - 19 years : < 7.5 | -------------------------------------------------------------------------------

    Note: 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a

    diabetic patient who is recently under good control may still have a high concentration of

    HbA1c. Converse is true for a diabetic previously under good control but now poorly

    controlled .

    2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long

    life expectancy and no significant cardiovascular disease. In patients with significant

    complications of diabetes, limited life expectancy or extensive co-morbid conditions,

    targeting a goal of < 7.0 % may not be appropriate.

    Comments

    HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better

    indicator of long term glycemic control as compared to blood and urinary glucose determinations.

    ADA criteria for correlation between HbA1c & Mean plasma glucose levels

    --------------------------------------- | HbA1c(%) | Mean Plasma Glucose (mg/dL)| |----------|----------------------------| | 6 | 126 | |----------|----------------------------| | 7 | 154 | |----------|----------------------------| | 8 | 183 | |----------|----------------------------|

    PatientReportSCSuperPanel.HBELECTRO_SC (Version: 4)

    .

    Page 2 of 4

  • S02 - DR ANMOL_S

    ULTRASOUND CLINIC

    C-308, 3RD FLR, NIRWANA

    COUNTRY, SOUTH CITY

    GURGAON

    Name

    A/c Status

    Lab No.

    Ref By :

    Gender:Age:

    Report Status

    Reported

    Received

    Collected

    P

    19/4/2014 4:55:05PM

    :

    :

    :

    :

    :

    :

    : Final

    35 Years

    19/4/2014 12:11:00PM

    19/4/2014 12:22:25PM107521815 Female

    SELF

    Ms. SUGANTHI

    Test Name Results Units Ref. Range | 9 | 212 | |----------|----------------------------| | 10 | 240 | |----------|----------------------------| | 11 | 269 | |----------|----------------------------| | 12 | 298 | ---------------------------------------

    PatientReportSCSuperPanel.HBELECTRO_SC (Version: 4)

    .

    Page 3 of 4

  • S02 - DR ANMOL_S

    ULTRASOUND CLINIC

    C-308, 3RD FLR, NIRWANA

    COUNTRY, SOUTH CITY

    GURGAON

    Name

    A/c Status

    Lab No.

    Ref By :

    Gender: Age:

    Report Status

    Reported

    Received

    Collected

    P

    19/4/2014 4:55:19PM

    :

    :

    :

    :

    :

    :

    : Final

    35 Years

    19/4/2014 12:11:00PM

    19/4/2014 12:22:25PM107521815 Female

    SELF

    Ms. SUGANTHI

    Test Name Results Units Ref. Range

    GLUCOSE, FASTING (F) AND POST MEAL, PLASMA

    (Hexokinase)

    80.00Glucose Fasting 70.00 - 100.00 mg/dL

    84.00Glucose (PP) 70.00 - 140.00 mg/dL

    Dr. Divya.Singh

    MD PATH

    Chief of Lab

    Dr. Sushrut Pownikar

    DNB (Pathology)

    HOD Hemat & Imm

    -------------------------------End of report --------------------------------

    PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 3)

    .

    Page 4 of 4